Teva Inks $225 Million Opioid-Related Settlement with Texas
- February 11, 2022
Teva Pharmaceuticals Industries has reached a $225 million settlement with Texas to resolve the state’s claims that the company played a role in fueling the opioid epidemic.
ARTICLE TAGS
You must be logged in to access this content.